Tango Therapeutics (TNGX) Times Interest Earned (2020 - 2026)
Tango Therapeutics' (TNGX) quarterly Times Interest Earned came in at -$0.16 in Q1 2026, up 99.99% year-on-year from -$0.08 in Q1 2025, and up 77.44% quarter-over-quarter from -$0.69 in Q4 2025.
Tango Therapeutics (TNGX) Times Interest Earned (2020 - 2026) Analysis & Trends
Tango Therapeutics' Times Interest Earned history runs 7 years deep, the most recent figure standing at -$0.16 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 99.99% year-over-year to -$0.16 in Q1 2026; TTM through Mar 2026 was -$0.37, a 99.99% increase from a year earlier, with the FY2025 full-year figure at -$0.6, up 35.93% from the prior year.
- Times Interest Earned climbed to -$0.16 in Q1 2026 per TNGX's latest filing, from -$0.69 in the prior quarter.
- Across five years, Times Interest Earned topped out at $0.24 in Q3 2025 and bottomed at -$1575.2 in Q1 2025.
- The 5-year median for Times Interest Earned is -$0.38 (2022), against an average of -$94.15.
- Across the five-year window, Times Interest Earned tumbled 343973.55% in 2024 and soared 123.45% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at -$0.38 in 2022, then slumped by 48.2% to -$0.56 in 2023, then tumbled by 3292.91% to -$18.96 in 2024, then jumped by 96.36% to -$0.69 in 2025, then soared by 77.44% to -$0.16 in 2026.
- Per Business Quant, the three latest TNGX Times Interest Earned figures stand at -$0.16 (Q1 2026), -$0.69 (Q4 2025), and $0.24 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Tango Therapeutics | 3.94 Bn | 3.78 Bn | - | -0.16 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.16 |
| Dec 31, 2025 | -0.69 |
| Sep 30, 2025 | 0.24 |
| Jun 30, 2025 | -1.97 |
| Mar 31, 2025 | -1,575.19 |
| Dec 31, 2024 | -18.96 |
| Sep 30, 2024 | -1.00 |
| Jun 30, 2024 | -0.69 |
| Mar 31, 2024 | -1.14 |
| Dec 31, 2023 | -0.56 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | -0.01 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | -0.38 |
| Sep 30, 2022 | -0.01 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | -0.44 |
| Sep 30, 2021 | 0.00 |
| Dec 31, 2020 | -0.01 |